EX-10.1 2 dex101.htm SECURITIES PURCHASE AGREEMENT

Securities Purchase Agreement
EX-10.1 2 dex101.htm SECURITIES PURCHASE AGREEMENT
Exhibit 10.1
SECURITIES PURCHASE AGREEMENT
This Securities Purchase Agreement (this “Agreement”) is dated as of August 30, 2007, among Veri-Tek
International, Corp., a Michigan corporation (the “Company”), and the investors listed on the Schedule of
Buyers attached hereto as Annex A and identified on the signature pages hereto (each, an “Investor” and
collectively, the “Investors”).
WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(2) of the
Securities Act (as defined below) and Rule 506 promulgated thereunder, the Company desires to issue and sell to
each Investor, and each Investor, severally and not jointly, desires to purchase from the Company certain
securities of the Company, as more fully described in this Agreement.
NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for
other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company
and the Investors agree as follows:
ARTICLE 1.
DEFINITIONS
1.1. Definitions. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement,
the following terms shall have the meanings indicated in this Section 1.1:
“Action” means any action, suit, inquiry, notice of violation, proceeding (including any partial proceeding such
as a deposition) or investigation pending or threatened against or affecting the Company, any Subsidiary or any
of their respective properties, with respect to which the Company has received written notice, before or by any
court, arbitrator, governmental or administrative agency, regulatory authority (federal, state, county, local or
foreign), stock market, stock exchange or trading facility.
“Affiliate” means any Person that, directly or indirectly through one or more intermediaries, controls or is
controlled by or is under common control with a Person, as such terms are used in and construed under Rule 144.
“Business Day” means any day except Saturday, Sunday and any day which is a federal legal holiday in the
United States or a day on which banking institutions in the State of New York or State of Illinois are authorized
or required by law or other governmental action to close.
“Buy-In” has the meaning set forth in Section 4.1(c).
“Closing” means the closing of the purchase and sale of the Shares pursuant to Article II.
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (1 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
“Closing Date” means the Business Day on which all of the conditions set forth in Sections 5.1 and 5.2 hereof
are satisfied, or such other date as the parties may agree.
“Commission” means the Securities and Exchange Commission.
“Common Stock” means the common stock of the Company, no par value per share, and any securities into
which such common stock may hereafter be reclassified.
“Common Stock Equivalents” means any securities of the Company or any Subsidiary which entitle the holder
thereof to acquire Common Stock at any time, including without limitation, any debt, preferred stock, rights,
options, warrants or other instrument that is at any time convertible into or exchangeable for, or otherwise entitles
the holder thereof to receive, Common Stock or other securities that entitle the holder to receive, directly or
indirectly, Common Stock.
“Company Counsel” means Foley & Lardner LLP.
“Company Deliverables” has the meaning set forth in Section 2.2(a).
“Delivered Shares” has the meaning set forth in Section 4.1(d).
“Disclosure Materials” has the meaning set forth in Section 3.1(h).
“Effective Date” means the date that the Registration Statement required by Section 2(a) of the Registration
Rights Agreement is first declared effective by the Commission.
“Exchange Act” means the Securities Exchange Act of 1934, as amended.
“GAAP” means U.S. generally accepted accounting principles.
“Intellectual Property Rights” has the meaning set forth in Section 3.1(p).
“Investment Amount” means, with respect to each Investor, the Investment Amount indicated on such
Investor’s signature page to this Agreement.
“Investor Deliverables” has the meaning set forth in Section 2.2(b).
“Investor Party” has the meaning set forth in Section 4.7.
“Legend Removal Date” has the meaning set forth in Section 4.1(c).
“Lien” means any lien, charge, encumbrance, security interest, right of first refusal or other restrictions of any
kind.
“Losses” has the meaning set forth in Section 4.7.
“Material Adverse Effect” means any of (i) a material and adverse effect on the legality, validity or
enforceability of any Transaction Document, (ii) a material and adverse
2
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (2 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (3 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
effect on the results of operations, assets, prospects, business or condition (financial or otherwise) of the
Company and the Subsidiaries, taken as a whole, or (iii) an adverse impairment to the Company’s ability to
perform on a timely basis its obligations under any Transaction Document.
“Money Laundering Laws” has the meaning set forth in Section 3.1(dd).
“New York Courts” means the state and federal courts sitting in the City of New York, Borough of Manhattan.
“OFAC” has the meaning set forth in Section 3.1(cc).
“Outside Date” means the thirtieth (30th) calendar day following the date of this Agreement; provided, that if
such day should fall on a day that is not a Business Day, the Outside Date shall be deemed the next day that is a
Business Day.
“Per Share Purchase Price” equals $6.00.
“Person” means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint
venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or
other entity of any kind.
“Proceeding” means an action, claim, suit, investigation or proceeding (including, without limitation, an
investigation or partial proceeding, such as a deposition), whether commenced or threatened.
“Registration Rights Agreement” means the Registration Rights Agreement, dated as of the date of this
Agreement, among the Company and the Investors, in the form of Exhibit A hereto.
“Registration Statement” means a registration statement meeting the requirements set forth in the Registration
Rights Agreement and covering the resale by the Investors of the Shares.
“Rule 144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may
be amended from time to time, or any similar rule or regulation hereafter adopted by the Commission having
substantially the same effect as such Rule.
“SEC Reports” has the meaning set forth in Section 3.1(h).
“Securities Act” means the Securities Act of 1933, as amended.
“Share Delivery Date” has the meaning set forth in Section 4.1(c).
“Shares” means the shares of Common Stock issued or issuable to the Investors pursuant to this Agreement.
3
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (4 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
“Short Sales” include, without limitation, all “short sales” as defined in Rule 200 promulgated under Regulation
SHO under the Exchange Act and all types of direct and indirect stock pledges, forward sale contracts, options,
puts, calls, swaps and similar arrangements (including on a total return basis), and sales and other transactions
through non-US broker dealers or foreign regulated brokers.
“Subsidiary” means any “significant subsidiary” as defined in Rule 1-02(w) of the Regulation S-X promulgated
by the Commission under the Exchange Act.
“Trading Day” means (i) a day on which the Common Stock is traded on a Trading Market (other than the OTC
Bulletin Board), or (ii) if the Common Stock is not listed on a Trading Market (other than the OTC Bulletin
Board), a day on which the Common Stock is traded in the over-the-counter market, as reported by the OTC
Bulletin Board, or (iii) if the Common Stock is not quoted on any Trading Market, a day on which the Common
Stock is quoted in the over-the-counter market as reported by the Pink Sheets LLC (or any similar organization or
agency succeeding to its functions of reporting prices); provided, that in the event that the Common Stock is not
listed or quoted as set forth in (i), (ii) and (iii) hereof, then Trading Day shall mean a Business Day.
“Trading Market” means whichever of the New York Stock Exchange, the American Stock Exchange, the
NASDAQ Global Select Market, the NASDAQ Global Market, the NASDAQ Capital Market or OTC Bulletin
Board on which the Common Stock is listed or quoted for trading on the date in question.
“Transaction Documents” means this Agreement, the Registration Rights Agreement and any other documents
or agreements executed in connection with the transactions contemplated hereunder.
ARTICLE 2.
PURCHASE AND SALE
2.1. Closing. Subject to the terms and conditions set forth in this Agreement, at the Closing the Company shall
issue and sell to each Investor, and each Investor shall, severally and not jointly, purchase from the Company, the
Shares representing such Investor’s Investment Amount. The Closing shall take place at the offices of Bryan
Cave LLP, 1290 Avenue of the Americas, New York, NY 10104 on the Closing Date or at such other location or
time as the parties may agree.
2.2. Closing Deliveries. (a) At the Closing, the Company shall deliver or cause to be delivered to each Investor
the following (the “Company Deliverables”):
(i) a certificate evidencing a number of Shares equal to such Investor’s Investment Amount divided by the Per
Share Purchase Price, registered in the name of such Investor;
(ii) the legal opinion of Company Counsel, in agreed form, addressed to the Investors; and
4
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (5 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
(iii) the Registration Rights Agreement, duly executed by the Company.
(b) At the Closing, each Investor shall deliver or cause to be delivered to the Company the following (the
“Investor Deliverables”):
(i) its Investment Amount, in United States dollars and in immediately available funds, by wire transfer to an
account designated in writing by the Company for such purpose; and
(ii) the Registration Rights Agreement, duly executed by such Investor.
ARTICLE 3.
REPRESENTATIONS AND WARRANTIES
3.1. Representations and Warranties of the Company. The Company hereby makes the following representations
and warranties to each Investor:
(a) Subsidiaries. The Company has no direct or indirect Subsidiaries other than as specified in the SEC Reports.
Except for Liens held by Comerica Bank, the Company owns, directly or indirectly, all of the capital stock of
each Subsidiary free and clear of any and all Liens, and all the issued and outstanding shares of capital stock of
each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights.
(b) Organization and Qualification. The Company and each Subsidiary are duly incorporated or otherwise
organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation or
organization (as applicable), with the requisite power and authority to own and use its properties and assets and
to carry on its business as currently conducted. Neither the Company nor any Subsidiary is in violation of any of
the provisions of its respective certificate or articles of incorporation, bylaws or other organizational or charter
documents. The Company and each Subsidiary are duly qualified to conduct its respective businesses and are in
good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business
conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified
or in good standing, as the case may be, could not, individually or in the aggregate, have or reasonably be
expected to result in a Material Adverse Effect.
(c) Authorization; Enforcement. The Company has the requisite corporate power and authority to enter into and
to consummate the transactions contemplated by each of the Transaction Documents and otherwise to carry out
its obligations thereunder. The execution and delivery of each of the Transaction Documents by the Company
and the consummation by it of the transactions contemplated thereby have been duly authorized by all necessary
action on the part of the Company and no further action is required by the Company in connection therewith.
Each Transaction Document has been (or upon delivery will have been) duly executed by the Company and,
when delivered in accordance with the terms hereof, will constitute the valid and binding obligation of the
Company enforceable against the Company in
5
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (6 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency,
reorganization, moratorium, liquidation or similar laws relating to, or affecting generally the enforcement of,
creditors’ rights and remedies or by other equitable principles of general application.
(d) No Conflicts. The execution, delivery and performance of the Transaction Documents by the Company and
the consummation by the Company of the transactions contemplated thereby do not and will not (i) conflict with
or violate any provision of the Company’s or any Subsidiary’s certificate or articles of incorporation, bylaws or
other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that with notice
or lapse of time or both would become a default) under, or give to others any rights of termination, amendment,
acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt
or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the
Company or any Subsidiary is a party or by which any property or asset of the Company or any Subsidiary is
bound or affected, except which are the subject of written waivers or consents that have been obtained or effected
on or prior to the Closing Date, or (iii) result in a violation of any law, rule, regulation, order, judgment,
injunction, decree or other restriction of any court or governmental authority to which the Company or a
Subsidiary is subject (including federal and state securities laws and regulations), or by which any property or
asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such
as could not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse
Effect.
(e) Filings, Consents and Approvals. The Company is not required to obtain any consent, waiver, authorization or
order of, give any notice to, or make any filing or registration with, any court or other federal, state, local or other
governmental authority or other Person in connection with the execution, delivery and performance by the
Company of the Transaction Documents, other than (i) the filing with the Commission of one or more
Registration Statements in accordance with the requirements of the Registration Rights Agreement, (ii) filings
required by state securities laws, (iii) the filing of a Notice of Sale of Securities on Form D with the Commission
under Regulation D of the Securities Act, (iv) the filings required in accordance with Section 4.5 and (v) those
that have been made or obtained prior to the date of this Agreement.
(f) Issuance of the Shares. The Shares have been duly authorized and, when issued and paid for in accordance
with the Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of
all Liens. The Company has reserved from its duly authorized capital stock the shares of Common Stock issuable
pursuant to this Agreement in order to issue the Shares.
(g) Capitalization. The number of shares and type of all authorized, issued and outstanding capital stock of the
Company, and all shares of Common Stock reserved for issuance under the Company’s various option and
incentive plans, is specified in the SEC Reports. Except as specified in the SEC Reports, no securities of the
Company are entitled to preemptive or similar rights, and no Person has any right of first refusal, preemptive
right, right of participation, or any similar right to participate in the transactions contemplated by the
6
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (7 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
Transaction Documents. Except as specified in the SEC Reports, there are no outstanding options, warrants, scrip
rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or
obligations convertible into or exchangeable for, or giving any Person any right to subscribe for or acquire, any
shares of Common Stock, or contracts, commitments, understandings or arrangements by which the Company or
any Subsidiary is or may become bound to issue additional shares of Common Stock, or securities or rights
convertible or exchangeable into shares of Common Stock. The issue and sale of the Shares will not, immediately
or with the passage of time, obligate the Company to issue shares of Common Stock or other securities to any
Person (other than the Investors) and will not result in a right of any holder of Company securities to adjust the
exercise, conversion, exchange or reset price under such securities.
(h) SEC Reports; Financial Statements. The Company has filed all reports required to be filed by it under the
Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the twelve months
preceding the date hereof (or such shorter period as the Company was required by law to file such reports) (the
foregoing materials being collectively referred to herein as the “SEC Reports” and, together with the Schedules
to this Agreement (if any), the “Disclosure Materials”) on a timely basis or has timely filed a valid extension of
such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. Except as
specified in amendments to the SEC Reports, which have been filed with the Commission as of the date hereof,
as of their respective dates, the SEC Reports complied in all material respects with the requirements of the
Securities Act and the Exchange Act and the rules and regulations of the Commission promulgated thereunder,
and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a
material fact required to be stated therein or necessary in order to make the statements therein, in light of the
circumstances under which they were made, not misleading. The financial statements of the Company included
in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and
regulations of the Commission with respect thereto as in effect at the time of filing, except as specified in
amendments to the SEC Reports, which have been filed with the Commission as of the date hereof. Such
financial statements have been prepared in accordance with GAAP applied on a consistent basis during the
periods involved, except (i) as may be otherwise specified in such financial statements or the notes thereto or
(ii) in the case of unaudited interim statements, to the extent they may exclude footnotes or may be condensed or
contain summary statements, and fairly present in all material respects the financial position of the Company and
its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the
periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit
adjustments.
(i) Press Releases. The press releases disseminated by the Company during the twelve months preceding the date
of this Agreement taken as a whole do not contain any untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary in order to make the statements therein, in light of the
circumstances under which they were made and when made, not misleading.
(j) Material Changes. Since the date of the latest audited financial statements included within the SEC Reports,
except as specifically disclosed in the SEC Reports, (i) there
7
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (8 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
has been no event, occurrence or development that has had or that could reasonably be expected to result in a
Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent or otherwise) other than
(A) trade payables, accrued expenses and other liabilities incurred in the ordinary course of business consistent
with past practice and (B) liabilities not required to be reflected in the Company’s financial statements pursuant
to GAAP or required to be disclosed in filings made with the Commission, (iii) the Company has not altered its
method of accounting or the identity of its auditors, (iv) the Company has not declared or made any dividend or
distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to
purchase or redeem any shares of its capital stock, and (v) the Company has not issued any equity securities to
any officer, director or Affiliate, except pursuant to existing Company stock option plans. The Company does not
have pending before the Commission any request for confidential treatment of information.
(k) Litigation. There is no Action which (i) adversely affects or challenges the legality, validity or enforceability
of any of the Transaction Documents or the Shares or (ii) except as specifically disclosed in the SEC Reports,
would, if there were an unfavorable decision, individually or in the aggregate, have or reasonably be expected to
result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor any director or officer thereof
(in his or her capacity as such), is or has been the subject of any Action involving a claim of violation of or
liability under federal or state securities laws or a claim of breach of fiduciary duty, except as specifically
disclosed in the SEC Reports. There has not been, and to the knowledge of the Company, there is not pending
any investigation by the Commission involving the Company or any current or former director or officer of the
Company (in his or her capacity as such). The Commission has not issued any stop order or other order
suspending the effectiveness of any registration statement filed by the Company or any Subsidiary under the
Exchange Act or the Securities Act.
(l) Labor Relations. No material labor dispute exists or, to the knowledge of the Company, is imminent with
respect to any of the employees of the Company.
(m) Compliance. Neither the Company nor any Subsidiary (i) is in default under or in violation of (and no event
has occurred that has not been waived that, with notice or lapse of time or both, would result in a default by the
Company or any Subsidiary under), nor has the Company or any Subsidiary received notice of a claim that it is in
default under or that it is in violation of, any indenture, loan or credit agreement or any other agreement or
instrument to which it is a party or by which it or any of its properties is bound (whether or not such default or
violation has been waived), (ii) is in violation of any order of any court, arbitrator or governmental body, or
(iii) is or has been in violation of any statute, rule or regulation of any governmental authority, including without
limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health
and safety, product quality and safety and employment and labor matters, except in each case as would not,
individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect. The
Company is in compliance with all effective requirements of the Sarbanes-Oxley Act of 2002, as amended, and
the rules and regulations thereunder, that are applicable to it, except where such noncompliance would not have
or reasonably be expected to result in a Material Adverse Effect.
8
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (9 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
(n) Regulatory Permits. The Company and the Subsidiaries possess all certificates, authorizations and permits
issued by the appropriate federal, state, local or foreign regulatory authorities necessary to conduct their
respective businesses as described in the SEC Reports, except where the failure to possess such permits could
not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect, and
neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or
modification of any such permits.
(o) Title to Assets. The Company and the Subsidiaries have good and marketable title in fee simple to all real
property owned by them that is material to their respective businesses and good and marketable title in all
personal property owned by them that is material to their respective businesses, in each case free and clear of all
Liens, except for Liens (i) held by Comerica Bank, or (ii) as do not materially affect the value of such property or
do not materially interfere with the use made and proposed to be made of such property by the Company and the
Subsidiaries. Any real property and facilities held under lease by the Company and the Subsidiaries are held by
them under valid, subsisting and enforceable leases of which the Company and the Subsidiaries are in
compliance, except as could not, individually or in the aggregate, have or reasonably be expected to result in a
Material Adverse Effect.
(p) Patents and Trademarks. The Company and the Subsidiaries have, or have rights to use, all patents, patent
applications, trademarks, trademark applications, service marks, trade names, copyrights, licenses and other
similar rights that are necessary or material for use in connection with their respective businesses as described in
the SEC Reports and which the failure to so have could, individually or in the aggregate, have or reasonably be
expected to result in a Material Adverse Effect (collectively, the “Intellectual Property Rights”). Neither the
Company nor any Subsidiary has received a written notice that the Intellectual Property Rights used by the
Company or any Subsidiary violates or infringes upon the rights of any Person. Except as set forth in the SEC
Reports, to the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no
existing infringement by another Person of any of the Intellectual Property Rights.
(q) Insurance. The Company and the Subsidiaries are insured by insurers of recognized financial responsibility
against such losses and risks and in such amounts as are prudent and customary in the businesses in which the
Company and the Subsidiaries are engaged. The Company has no reason to believe that it will not be able to
renew its and the Subsidiaries’ existing insurance coverage as and when such coverage expires or to obtain
similar coverage from similar insurers as may be necessary to continue its business on terms consistent with
market for the Company’s and such Subsidiaries’ respective lines of business.
(r) Transactions With Affiliates and Employees. Except (i) as set forth in the SEC Reports and (ii) for the Lease
Agreement and Transition Services Agreement each entered into by the Company in connection with that certain
Asset Purchase Agreement, dated as of July 31, 2007, by and among on the one hand, the Company and certain
of its Subsidiaries, and on the other hand, GT Distribution, LLC and certain of its subsidiaries, none of the
officers or directors of the Company and, to the knowledge of the Company, none of the employees of the
Company is presently a party to any transaction with the Company or any Subsidiary (other than for
9
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (10 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
services as employees, officers and directors), including any contract, agreement or other arrangement providing
for the furnishing of services to or by, providing for rental of real or personal property to or from, or otherwise
requiring payments to or from any officer, director or such employee or, to the knowledge of the Company, any
entity in which any officer, director, or any such employee has a substantial interest or is an officer, director,
trustee or partner.
(s) Internal Accounting Controls. The Company and the Subsidiaries maintain a system of internal accounting
controls sufficient to provide reasonable assurance that (i) transactions are executed in accordance with
management’s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation
of financial statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is
permitted only in accordance with management’s general or specific authorization, and (iv) the recorded
accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is
taken with respect to any differences.
(t) Certain Fees. Except for commissions payable to Roth Capital Partners, LLC, no brokerage or finder’s fees or
commissions are or will be payable by the Company to any broker, financial advisor or consultant, finder,
placement agent, investment banker, bank or other Person with respect to the transactions contemplated by this
Agreement. The Investors shall have no obligation with respect to any fees or with respect to any claims (other
than such fees or commissions owed by an Investor pursuant to written agreements executed by such Investor
which fees or commissions shall be the sole responsibility of such Investor) made by or on behalf of other
Persons for fees of a type contemplated in this Section that may be due in connection with the transactions
contemplated by this Agreement.
(u) Certain Registration Matters. Assuming the accuracy of the Investors’ representations and warranties set forth
in Section 3.2(b)-(e), no registration under the Securities Act is required for the offer and sale of the Shares by
the Company to the Investors under the Transaction Documents. The Company is eligible to register its Common
Stock for resale by the Investors under Form S-3 promulgated under the Securities Act. Except with respect to
the Company’s ongoing obligation (as contemplated by that certain Registration Rights Agreement, dated as of
November 3, 2006, by and among the Company and the investors named therein) to keep that certain Form S-3
(File No. 333-139576) as filed with the Commission on December 21, 2006 effective for the entire Effectiveness
Period (as defined in such Registration Rights Agreement, dated as of November 3, 2006), the Company has not
granted or agreed to grant to any Person any rights (including “piggy-back” registration rights) to have any
securities of the Company registered with the Commission or any other governmental authority that have not
been satisfied.
(v) Listing and Maintenance Requirements. Except as specified in the SEC Reports, the Company has not, in the
two years preceding the date hereof, received written notice from any Trading Market to the effect that the
Company is not in compliance with the listing or maintenance requirements thereof. The Company is, and has no
reason to believe that it will not in the foreseeable future continue to be, in compliance with the listing and
maintenance requirements for continued listing of the Common Stock on the Trading Market on which the
Common Stock is currently listed or quoted. The issuance and sale of the Shares under the
10
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (11 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
Transaction Documents does not contravene the rules and regulations of the Trading Market on which the
Common Stock is currently listed or quoted, and no approval of the shareholders of the Company thereunder is
required for the Company to issue and deliver to the Investors the Shares contemplated by Transaction
Documents.
(w) Investment Company. The Company is not, and is not an Affiliate of, and immediately following the Closing
will not have become, an “investment company” within the meaning of the Investment Company Act of 1940, as
amended.
(x) Application of Takeover Protections. The Company has taken all necessary action, if any, in order to render
inapplicable any control share acquisition, business combination, poison pill (including any distribution under a
rights agreement) or other similar anti-takeover provision under the Company’s Articles of Incorporation (or
similar charter documents) or the laws of its state of incorporation that is or could become applicable to the
Investors as a result of the Investors and the Company fulfilling their obligations or exercising their rights under
the Transaction Documents, including without limitation the Company’s issuance of the Shares and the
Investors’ ownership of the Shares.
(y) No Additional Agreements. The Company does not have any agreement or understanding with any Investor
with respect to the transactions contemplated by the Transaction Documents other than as specified in the
Transaction Documents.
(z) Consultation with Auditors. The Company has consulted its independent auditors concerning the accounting
treatment of the transactions contemplated by the Transaction Documents, and in connection therewith has
furnished such auditors complete copies of the Transaction Documents.
(aa) Foreign Corrupt Practices Act. Neither the Company nor any Subsidiary, nor to the knowledge of the
Company, any agent or other person acting on behalf of any of the Company or any Subsidiary, has, directly or
indirectly, (i) used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses related
to foreign or domestic political activity, (ii) made any unlawful payment to foreign or domestic government
officials or employees or to any foreign or domestic political parties or campaigns from corporate funds,
(iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any Person
acting on their behalf of which the Company is aware) which is in violation of law, or (iv) has violated in any
material respect any provision of the Foreign Corrupt Practices Act of 1977, as amended, and the rules and
regulations thereunder.
(bb) PFIC. Neither the Company nor any Subsidiary is a “passive foreign investment company” within the
meaning of Section 1297 of the U.S. Internal Revenue Code of 1986, as amended.
(cc) OFAC. Neither the Company nor any Subsidiary nor, to the knowledge of the Company, any director,
officer, agent, employee, Affiliate or Person acting on behalf of the Company or any Subsidiary is currently
subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury
Department (“OFAC”); and the Company will not use the proceeds of the sale of the Shares, or lend, contribute
or otherwise make available
11
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (12 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
such proceeds to any Subsidiary, joint venture partner or other Person or entity, towards any sales or operations
in Cuba, Iran, Syria, Sudan, Myanmar or any other country sanctioned by OFAC or for the purpose of financing
the activities of any Person currently subject to any U.S. sanctions administered by OFAC.
(dd) Money Laundering Laws. The operations of each of the Company and any Subsidiary are and have been
conducted at all times in compliance with the money laundering statutes of applicable jurisdictions, the rules and
regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced
by any applicable governmental agency (collectively, the “Money Laundering Laws”) and no action, suit or
proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the
Company and/or any Subsidiary with respect to the Money Laundering Laws is pending or, to the best
knowledge of the Company, threatened.
(ee) Disclosure. The Company confirms that neither it nor any Person acting on its behalf has provided any
Investor or its respective agents or counsel with any information that the Company believes constitutes material,
non-public information except insofar as the existence and terms of the proposed transactions hereunder may
constitute such information. The Company understands and confirms that the Investors will rely on the foregoing
representations and covenants in effecting transactions in securities of the Company. All disclosure provided to
the Investors regarding the Company, its business and the transactions contemplated hereby, furnished by or on
behalf of the Company (including the Company’s representations and warranties set forth in this Agreement) are
true and correct and do not contain any untrue statement of a material fact or omit to state any material fact
necessary in order to make the statements made therein, in light of the circumstances under which they were
made, not misleading.
Each Investor, for itself and for no other Investor, acknowledges and agrees that the Company has neither made
nor makes any representations or warranties with respect to the transactions contemplated hereby other than those
specifically set forth in this Section 3.1.
3.2. Representations and Warranties of the Investors. Each Investor hereby, for itself and for no other Investor,
represents and warrants to the Company as follows:
(a) Organization; Authority. Such Investor is an entity duly organized, validly existing and in good standing
under the laws of the jurisdiction of its organization with the requisite corporate or partnership power and
authority to enter into and to consummate the transactions contemplated by the applicable Transaction
Documents and otherwise to carry out its obligations thereunder. The execution, delivery and performance by
such Investor of the transactions contemplated by this Agreement has been duly authorized by all necessary
corporate or, if such Investor is not a corporation, such partnership, limited liability company or other applicable
like action, on the part of such Investor. Each of this Agreement and the Registration Rights Agreement has been
duly executed by such Investor, and when delivered by such Investor in accordance with the terms hereof, will
constitute the valid and legally binding obligation of such Investor, enforceable against it in accordance with its
terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization,
moratorium, liquidation or similar laws relating to, or affecting generally the enforcement of, creditors’ rights and
remedies or by other equitable principles of general application.
12
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (13 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
(b) Investment Intent. Such Investor is acquiring the Shares as principal for its own account for investment
purposes only and not with a view to or for distributing or reselling such Shares or any part thereof, without
prejudice, however, to such Investor’s right at all times to sell or otherwise dispose of all or any part of such
Shares in compliance with applicable federal and state securities laws. Subject to the immediately preceding
sentence, nothing contained herein shall be deemed a representation or warranty by such Investor to hold the
Shares for any period of time. Such Investor is acquiring the Shares hereunder in the ordinary course of its
business. Such Investor does not have any agreement or understanding, directly or indirectly, with any Person to
distribute any of the Shares.
(c) Investor Status. At the time such Investor was offered the Shares and at the date hereof it is, an “accredited
investor” as defined in Rule 501(a) under the Securities Act. Such Investor is not a registered broker-dealer under
Section 15 of the Exchange Act. Such Investor acknowledges and understands that its investment in the Shares
involves a significant degree of risk. Such Investor has such knowledge and experience in financial and business
matters that such Investor is capable of evaluating the merits and risks of such Investor’s prospective investment
in the Company and has the ability to bear the economic risk of the investment in the Shares. Such Investor has
been advised and understands that the Company is relying upon the accuracy of the Investors’ representations
and warranties set forth in Section 3.2(b)-(e) in concluding that no registration under the Securities Act is
required for the offer and sale of the Shares by the Company to the Investors under the Transaction Documents.
(d) General Solicitation. Such Investor is not purchasing the Shares as a result of any advertisement, article,
notice or other communication regarding the Shares published in any newspaper, magazine or similar media or
broadcast over television or radio or presented at any seminar or any other general solicitation or general
advertisement.
(e) Access to Information. Such Investor acknowledges that it has reviewed the Disclosure Materials and has
been afforded (i) the opportunity to ask such questions as it has deemed necessary of, and to receive answers
from, representatives of the Company concerning the terms and conditions of the offering of the Shares and the
merits and risks of investing in the Shares; (ii) access to information about the Company and the Subsidiaries and
their respective financial condition, results of operations, business, properties, management and prospects
sufficient to enable it to evaluate its investment; and (iii) the opportunity to obtain such additional information
that the Company possesses or can acquire without unreasonable effort or expense that is necessary to make an
informed investment decision with respect to the investment. Neither such inquiries nor any other investigation
conducted by or on behalf of such Investor or its representatives or counsel shall modify, amend or affect such
Investor’s right to rely on the truth, accuracy and completeness of the Disclosure Materials and the Company’s
representations and warranties contained in the Transaction Documents.
(f) Certain Trading Activities. Such Investor has not directly or indirectly, nor has any Person acting on behalf of
or pursuant to any understanding with such Investor,
13
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (14 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
engaged in any transactions in the securities of the Company (including, without limitations, any Short Sales
involving the Company’s securities) since the time that such Investor was first contacted by the Company or
Roth Capital Partners, LLC regarding an investment in the Company. Such Investor covenants that neither it nor
any Person acting on its behalf or pursuant to any understanding with it will engage in any transactions in the
securities of the Company (including Short Sales) prior to the time that the transactions contemplated by this
Agreement are publicly disclosed. Each Investor understands and acknowledges, that the Commission currently
takes the position that coverage of Short Sales “against the box” prior to the Effective Date of the Registration
Statement is a violation of Section 5 of the Securities Act, as set forth in Item 65, Section A, of the Manual of
Publicly Available Telephone Interpretations, dated July 1997, compiled by the Office of Chief Counsel,
Division of Corporation Finance.
(g) Independent Investment Decision. Such Investor has independently evaluated the merits of its decision to
purchase Shares pursuant to the Transaction Documents, and such Investor confirms that it has not relied on the
advice of any other Investor’s business and/or legal counsel in making such decision. Such Investor has not relied
on the business or legal advice of Roth Capital Partners, LLC or any of its agents, counsel or Affiliates in making
its investment decision hereunder, and confirms that none of such Persons has made any representations or
warranties to such Investor in connection with the transactions contemplated by the Transaction Documents.
(h) Limited Ownership. The purchase by such Investor of the Shares issuable to it at the Closing will not result in
such Investor (individually or together with any other Person with whom such Investor has identified, or will
have identified, itself as part of a “group” in a public filing made with the Commission involving the Company’s
securities) acquiring, or obtaining the right to acquire, in excess of 19.999% of the outstanding shares of
Common Stock or the voting power of the Company on a post transaction basis that assumes that the Closing
shall have occurred. Such Investor does not presently intend to, alone or together with others, make a public
filing with the Commission to disclose that it has (or that it together with such other Persons have) acquired, or
obtained the right to acquire, as a result of the Closing (when added to any other securities of the Company that it
or they then own or have the right to acquire), in excess of 19.999% of the outstanding shares of Common Stock
or the voting power of the Company on a post transaction basis that assumes that the Closing shall have occurred.
The Company acknowledges and agrees that no Investor has made or makes any representations or warranties
with respect to the transactions contemplated hereby other than those specifically set forth in this Section 3.2.
ARTICLE 4.
OTHER AGREEMENTS OF THE PARTIES
4.1. (a) Shares may only be disposed of in compliance with state and federal securities laws. In connection with
any transfer of the Shares other than pursuant to an effective registration statement, to the Company, to an
Affiliate of an Investor who qualifies as an accredited investor under Regulation D of the Securities Act or in
connection with a pledge as contemplated in Section 4.1(b), the Company may require the transferor thereof to
provide to the
14
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (15 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
Company an opinion of counsel selected by the transferor but reasonably satisfactory to the Company, the form
and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer
does not require registration of such transferred Shares under the Securities Act.
(b) Certificates evidencing the Shares will contain the following legend, until such time as they are not required
under Section 4.1(c):
THESE SECURITIES HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND
EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN
RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF
1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE
OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR
IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE
SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS
EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT,
THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.
THESE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN
ACCOUNT SECURED BY SUCH SECURITIES.
The Company acknowledges and agrees that an Investor may from time to time pledge, and/or grant a security
interest in some or all of the Shares pursuant to a bona fide margin agreement in connection with a bona fide
margin account and, if required under the terms of such agreement or account, such Investor may transfer
pledged or secured Shares to the pledgees or secured parties. Such a pledge or transfer would not be subject to
approval or consent of the Company and no legal opinion of legal counsel to the pledgee, secured party or
pledgor shall be required in connection with the pledge, but such legal opinion may be required in connection
with a subsequent transfer following default by the Investor transferee of the pledge. No notice shall be required
of such pledge. At the appropriate Investor’s expense, the Company will execute and deliver such reasonable
documentation as a pledgee or secured party of Shares may reasonably request in connection with a pledge or
transfer of the Shares including the preparation and filing of any required prospectus supplement under Rule 424
(b)(3) of the Securities Act or other applicable provision of the Securities Act to appropriately amend the list of
Selling Stockholders thereunder. Except as otherwise provided in Section 4.1(c), any Shares subject to a pledge
or security interest as contemplated by this Section 4.1(b) shall continue to bear the legend set forth in this
Section 4.1(b) and be subject to the restrictions on transfer set forth in Section 4.1(a).
15
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (16 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
(c) Certificates evidencing Shares shall not contain any legend (including the legend set forth in Section 4.1(b)):
(i) following a sale or transfer of such Shares pursuant to an effective registration statement (including a
Registration Statement), or (ii) following a sale or transfer of such Shares pursuant to Rule 144 (assuming the
transferee is not an Affiliate of the Company), or (iii) while such Shares are eligible for sale under Rule 144(k). If
an Investor shall make a sale or transfer of Shares either (x) pursuant to Rule 144 or (y) pursuant to a registration
statement and in each case shall have delivered to the Company or the Company’s transfer agent the certificate
representing Shares containing a restrictive legend which are the subject of such sale or transfer and a
representation letter in customary form (the date of such sale or transfer and Share delivery being the “Share
Delivery Date”) and (1) the Company shall fail to deliver or cause to be delivered to such Investor a certificate
representing such Shares that is free from all restrictive or other legends not required by law by the third Trading
Day following the Share Delivery Date (the “Legend Removal Date”) and (2) following such third Trading Day
after the Share Delivery Date and prior to the time such Shares are received free from restrictive legends, the
Investor is required by its brokerage firm to purchase (in an open market transaction or otherwise) or the
Investor’s brokerage firm otherwise purchases pursuant to such firm’s policies and procedures shares of Common
Stock to deliver in satisfaction of a sale by the Investor of such Shares (a “Buy-In”), then the Company shall pay
in cash to the Investor (for costs incurred either directly by such Investor or on behalf of a third party) the amount
by which the total purchase price paid for Common Stock as a result of the Buy-In (including brokerage
commissions, if any) exceeds the product of (x) the aggregate number of shares of Common Stock sold by the
Investor which gave rise to the Buy-In multiplied by (y) the actual sale price at which the sell order giving rise to
such sale obligation was executed (including any brokerage commissions). The Investor shall provide the
Company written notice indicating the amounts payable to the Investor in respect of the Buy-In.
(d) In addition to the foregoing, in the event that an Investor shall have delivered to the Company or the
Company’s transfer agent a certificate representing Shares containing a restrictive legend for removal of such
restrictive legend in compliance with the provisions of this Section 4(c)(i), (ii) or (iii) (the “Delivered Shares”)
and the Company shall fail to deliver or cause to be delivered to such Investor a certificate representing such
Delivered Shares that is free from all restrictive or other legends not required by law by the Legend Removal
Date, then on the last day of each 30-day period after the Legend Removal Date (if such Investor has not received
the Delivered Shares free from all restrictive or other legends not required by law prior to such date) until such
Investor has received the Delivered Shares free from all restrictive or other legends not required by law, the
Company shall pay to such Investor, in cash, as partial liquidated damages and not as a penalty, an amount equal
to 1.0% of that portion of such Investor’s Investment Amount which is attributable to the Delivered Shares. The
partial liquidated damages pursuant to the terms hereof shall apply on a daily pro-rata basis for any portion of
each 30-day period prior to that date upon which such Investor has received the Delivered Shares free from all
restrictive or other legends not required by law and shall cease to accrue when such Investor receives the
Delivered Shares free from all restrictive or other legends not required by law.
4.2. Furnishing of Information. As long as any Investor owns the Shares, the Company covenants to timely file
(or obtain extensions in respect thereof and file within the
16
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (17 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to the
Exchange Act. As long as any Investor owns Shares, if the Company is not required to file reports pursuant to
such laws, it will prepare and furnish to the Investors and make publicly available in accordance with Rule 144(c)
such information as is required for the Investors to sell the Shares under Rule 144. The Company further
covenants that it will take such further action as any holder of Shares may reasonably request, all to the extent
required from time to time to enable such Person to sell the Shares without registration under the Securities Act
within the limitation of the exemptions provided by Rule 144.
4.3. Integration. The Company shall not, and shall use its best efforts to ensure that no Affiliate of the Company
shall, sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in
Section 2 of the Securities Act) that would be integrated with the offer or sale of the Shares in a manner that
would require the registration under the Securities Act of the sale of the Shares to the Investors, or that would be
integrated with the offer or sale of the Shares for purposes of the rules and regulations of any Trading Market in a
manner that would require stockholder approval of the sale of the securities to the Investors.
4.4. Subsequent Registrations. The Company may not file any registration statement (other than on Form S-8)
with the Commission with respect to any securities of the Company until the initial Registration Statement
required to be filed pursuant to Section 2(a) of the Registration Rights Agreement is declared effective by the
Commission, and the prospectus forming a portion of such Registration Statement is available for the resale of all
such shares of Common Stock included thereon; provided that this Section 4.4 shall not prohibit the Company
from filing amendments to registration statements filed prior to the date of this Agreement, so long as any such
amendment does not increase the number of securities covered thereby.
4.5. Securities Laws Disclosure; Publicity. By 9:30 a.m. (New York time) on the Trading Day following the
execution in full of this Agreement (provided that each Investor has executed and delivered a counterpart of this
Agreement before 8:30 a.m. (New York time) on such date), and by 9:30 a.m. (New York time) on the Trading
Day following the Closing Date, the Company shall issue press releases disclosing the transactions contemplated
hereby and the Closing. On the Trading Day following the execution of this Agreement the Company will file a
Current Report on Form 8-K disclosing the material terms of the Transaction Documents (and attach as exhibits
thereto the Transaction Documents), and on the Trading Day following the Closing Date the Company will file
an additional Current Report on Form 8-K to disclose the Closing. In addition, the Company will make such
other filings and notices in the manner and time required by the Commission and the Trading Market on which
the Common Stock is listed. Notwithstanding the foregoing, the Company shall not publicly disclose the name of
any Investor, or include the name of any Investor in any filing with the Commission (other than a Registration
Statement and any exhibits to filings made in respect of this transaction in accordance with periodic filing
requirements under the Exchange Act) or any regulatory agency or Trading Market, without the prior written
consent of such Investor, except to the extent such disclosure is required by law or Trading Market regulations.
Each Investor covenants that until such time as the transactions contemplated by this Agreement are publicly
disclosed by the Company as described above, such Investor will maintain the confidentiality of all disclosures
made to it in connection with this transaction (including the existence and terms of this transaction).
17
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (18 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
4.6. Limitation on Issuance of Future Priced Securities. During the six months following the Closing Date, the
Company shall not issue any “Future Priced Securities” as such term is described by NASD IM-4350-1.
4.7. Indemnification of Investors. In addition to the indemnity provided in the Registration Rights Agreement, the
Company will indemnify and hold the Investors and their directors, officers, shareholders, partners, employees
and agents (each, an “Investor Party”) harmless from any and all losses, liabilities, obligations, claims,
contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements, court costs
and reasonable attorneys’ fees and costs of investigation (collectively, “Losses”) that any such Investor Party
may suffer or incur as a result of or relating to any misrepresentation, breach or inaccuracy of any representation,
warranty, covenant or agreement made by the Company in any Transaction Document. In addition to the
indemnity contained herein, the Company will promptly reimburse each Investor Party for its reasonable legal
and other expenses (including the cost of any investigation, preparation and travel in connection therewith)
incurred in connection therewith, provided, that the Company may require such Investor Party to undertake to
reimburse all such fees and expenses to the extent it is finally judicially determined that such Investor Party is not
entitled to indemnification hereunder. Except as otherwise set forth herein, the mechanics and procedures with
respect to the rights and obligations under this Section 4.7 shall be the same as those set forth in Section 5 of the
Registration Rights Agreement.
4.8. Non-Public Information. The Company covenants and agrees that neither it nor any other Person acting on
its behalf will provide any Investor or its agents or counsel with any information that the Company believes
constitutes material non-public information, unless prior thereto such Investor shall have executed a written
agreement regarding the confidentiality and use of such information. The Company understands and confirms
that each Investor shall be relying on the foregoing representations in effecting transactions in securities of the
Company.
4.9. Listing of Shares. The Company agrees, (i) if the Company applies to have the Common Stock traded on any
other Trading Market, it will include in such application the Shares, and will take such other action as is
necessary or desirable to cause the Shares to be listed on such other Trading Market as promptly as possible, and
(ii) it will take all action reasonably necessary in the good faith judgment of the Company to continue the listing
and trading of its Common Stock on a Trading Market and will comply in all material respects with the
Company’s reporting, filing and other obligations under the bylaws or rules of the Trading Market.
4.10. Use of Proceeds. The Company will use the net proceeds from the sale of the Shares hereunder for working
capital or other general corporate purposes; provided that the Company will not use such proceeds to redeem any
Common Stock or Common Stock Equivalents.
18
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (19 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
ARTICLE 5.
CONDITIONS PRECEDENT TO CLOSING
5.1. Conditions Precedent to the Obligations of the Investors to Purchase Shares. The obligation of each Investor
to acquire Shares at the Closing is subject to the satisfaction or waiver by such Investor, at or before the Closing,
of each of the following conditions:
(a) Representations and Warranties. The representations and warranties of the Company contained herein shall be
true and correct in all material respects as of the date when made and as of the Closing as though made on and as
of such date;
(b) Performance. The Company shall have performed, satisfied and complied in all material respects with all
covenants, agreements and conditions required by the Transaction Documents to be performed, satisfied or
complied with by it at or prior to the Closing;
(c) No Injunction. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been
enacted, entered, promulgated or endorsed by any court or governmental authority of competent jurisdiction that
prohibits the consummation of any of the transactions contemplated by the Transaction Documents;
(d) Adverse Changes. Since the date of execution of this Agreement, no event or series of events shall have
occurred that reasonably could have or result in a Material Adverse Effect;
(e) No Suspensions of Trading in Common Stock; Listing. Trading in the Common Stock shall not have been
suspended by the Commission or any Trading Market (except for any suspensions of trading of not more than
one Trading Day solely to permit dissemination of material information regarding the Company) at any time
since the date of execution of this Agreement, and the Common Stock shall have been at all times since such date
listed for trading on a Trading Market;
(f) Company Deliverables. The Company shall have delivered the Company Deliverables in accordance with
Section 2.2(a);
(g) American Stock Exchange Approval. The American Stock Exchange shall have approved the American Stock
Exchange Additional Listing Application submitted by the Company with respect to the transactions
contemplated by the Transaction Documents; and
(h) Termination. This Agreement shall not have been terminated as to such Investor in accordance with
Section 6.5.
5.2. Conditions Precedent to the Obligations of the Company to sell Shares. The obligation of the Company to
sell Shares at the Closing is subject to the satisfaction or waiver by the Company, at or before the Closing, of
each of the following conditions:
19
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (20 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
(a) Representations and Warranties. The representations and warranties of each Investor contained herein shall be
true and correct in all material respects as of the date when made and as of the Closing Date as though made on
and as of such date;
(b) Performance. Each Investor shall have performed, satisfied and complied in all material respects with all
covenants, agreements and conditions required by the Transaction Documents to be performed, satisfied or
complied with by such Investor at or prior to the Closing;
(c) No Injunction. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been
enacted, entered, promulgated or endorsed by any court or governmental authority of competent jurisdiction that
prohibits the consummation of any of the transactions contemplated by the Transaction Documents;
(d) Investors Deliverables. Each Investor shall have delivered its Investors Deliverables in accordance with
Section 2.2(b);
(e) American Stock Exchange Approval. The American Stock Exchange shall have approved the American Stock
Exchange Additional Listing Application submitted by the Company with respect to the transactions
contemplated by the Transaction Documents; and
(f) Termination. This Agreement shall not have been terminated as to such Investor in accordance with
Section 6.5.
ARTICLE 6.
MISCELLANEOUS
6.1. Fees and Expenses. Each party shall pay the fees and expenses of its advisers, counsel, accountants and other
experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution,
delivery and performance of the Transaction Documents. The Company shall pay all stamp and other taxes and
duties levied in connection with the issuance of the Shares.
6.2. Entire Agreement. The Transaction Documents, together with the Exhibits and Schedules thereto, contain the
entire understanding of the parties with respect to the subject matter hereof and supersede all prior agreements,
understandings, discussions and representations, oral or written, with respect to such matters, which the parties
acknowledge have been merged into such documents, exhibits and schedules.
6.3. Notices. Any and all notices or other communications or deliveries required or permitted to be provided
hereunder shall be in writing and shall be deemed given and effective on the earliest of (a) the date of
transmission, if such notice or communication is delivered via facsimile (provided the sender receives a machinegenerated confirmation of successful transmission) at the facsimile number specified in this Section prior to 6:30
p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the date of transmission, if such
notice or communication is delivered via facsimile at the facsimile number specified in this Section on a day that
is not a Trading Day or later than 6:30 p.m. (New York City time) on any Trading Day,
20
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (21 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
(c) the Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service,
or (d) upon actual receipt by the party to whom such notice is required to be given. The address for such notices
and communications shall be as follows:
If to the Company: Veri-Tek International, Corp.
7402 W. 100th Place
Bridgeview, Illinois 60455
Attn: Chief Executive Officer
Facsimile: (248) 560-2000
With a copy to:
Foley & Lardner LLP
100 N. Tampa Street, Suite 2700
Tampa, Florida 33602
Attn: Carolyn Long
Facsimile: (813) 221-4210
If to an Investor:
To the address set forth under such Investor’s name on the signature pages
hereof;
or such other address as may be designated in writing hereafter, in the same manner, by such Person.
6.4. Amendments; Waivers; No Additional Consideration. No provision of this Agreement may be waived or
amended except in a written instrument signed, in the case of a waiver, by the party against whom enforcement
of any such waived provision is sought or, in the case of an amendment, by the Company and the Investors
holding a majority of the Shares, provided that such amendment shall apply with the same force and effect to all
Investors. No waiver of any default with respect to any provision, condition or requirement of this Agreement
shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any
other provision, condition or requirement hereof, nor shall any delay or omission of either party to exercise any
right hereunder in any manner impair the exercise of any such right. No consideration shall be offered or paid to
any Investor to amend or consent to a waiver or modification of any provision of any Transaction Document
unless the same consideration is also offered to all Investors who then hold Shares. Without the written consent
or the affirmative vote of each Investor affected thereby, an amendment or waiver under this Section 6.4 may not
waive or amend any Transaction Document the effect of which would be to permit the Company to (1) name any
Investor as an underwriter in a Registration Statement without such Investor’s specific written consent thereto, or
(2) not include any Registrable Securities (as defined in the Registration Rights Agreement) of an Investor in a
Registration Statement due to their refusal to be named as an underwriter therein; provided that this Section 6.4
shall not prohibit the Company from excluding any Registrable Securities of an Investor in a Registration
Statement in accordance with the terms of the Registration Rights Agreement.
6.5. Termination. This Agreement may be terminated prior to Closing:
(a) by written agreement of the Investors and the Company; and
21
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (22 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
(b) by the Company or an Investor (as to itself but no other Investor) upon written notice to the other, if the
Closing shall not have taken place by 6:30 p.m. Eastern time on the Outside Date; provided, that the right to
terminate this Agreement under this Section 6.5(b) shall not be available to any Person whose failure to comply
with its obligations under this Agreement has been the cause of or resulted in the failure of the Closing to occur
on or before such time.
In the event of a termination pursuant to this Section, the Company shall promptly notify all non-terminating
Investors. Upon a termination in accordance with this Section 6.5, the Company and the terminating Investor(s)
shall not have any further obligation or liability (including as arising from such termination) to the other and no
Investor will have any liability to any other Investor under the Transaction Documents as a result therefrom.
6.6. Construction. The headings herein are for convenience only, do not constitute a part of this Agreement and
shall not be deemed to limit or affect any of the provisions hereof. The language used in this Agreement will be
deemed to be the language chosen by the parties to express their mutual intent, and no rules of strict construction
will be applied against any party. This Agreement shall be construed as if drafted jointly by the parties, and no
presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any
provisions of this Agreement or any of the Transaction Documents.
6.7. Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and
their successors and permitted assigns. The Company may not assign this Agreement or any rights or obligations
hereunder without the prior written consent of the Investors. Any Investor may assign any or all of its rights
under this Agreement to any Person to whom such Investor assigns or transfers any Shares, provided such
transferee agrees in writing to be bound, with respect to the transferred Shares, by the provisions hereof that
apply to the “Investors” including, as applicable, the representations and warranties set forth in Section 3.2
hereof.
6.8. No Third-Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their
respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be
enforced by, any other Person, except as otherwise set forth in Section 4.7 (as to each Investor Party).
6.9. Governing Law. All questions concerning the construction, validity, enforcement and interpretation of this
Agreement shall be governed by and construed and enforced in accordance with the internal laws of the State of
New York, without regard to the principles of conflicts of law thereof. Each party agrees that all Proceedings
concerning the interpretations, enforcement and defense of the transactions contemplated by this Agreement and
any other Transaction Documents (whether brought against a party hereto or its respective Affiliates, employees
or agents) shall be commenced exclusively in the New York Courts. Each party hereto hereby irrevocably
submits to the exclusive jurisdiction of the New York Courts for the adjudication of any dispute hereunder or in
connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to
the enforcement of the any of the Transaction Documents), and hereby irrevocably waives, and agrees not to
assert in any
22
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (23 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
Proceeding, any claim that it is not personally subject to the jurisdiction of any such New York Court, or that
such Proceeding has been commenced in an improper or inconvenient forum. Each party hereto hereby
irrevocably waives personal service of process and consents to process being served in any such Proceeding by
mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such
party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute
good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in
any way any right to serve process in any manner permitted by law. Each party hereto hereby irrevocably waives,
to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising
out of or relating to this Agreement or the transactions contemplated hereby. If either party shall commence a
Proceeding to enforce any provisions of a Transaction Document, then the prevailing party in such Proceeding
shall be reimbursed by the other party for its reasonable attorneys’ fees and other costs and expenses incurred
with the investigation, preparation and prosecution of such Proceeding.
6.10. Survival. The representations, warranties, agreements and covenants contained herein shall survive for two
years following the Closing Date and the delivery of the Shares.
6.11. Execution. This Agreement may be executed in two or more counterparts, all of which when taken together
shall be considered one and the same agreement and shall become effective when counterparts have been signed
by each party and delivered to the other party, it being understood that both parties need not sign the same
counterpart. In the event that any signature is delivered by facsimile transmission or by e-mail delivery of a “.
pdf” format data file, such signature shall create a valid and binding obligation of the party executing (or on
whose behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf” signature
page were an original thereof.
6.12. Severability. If any provision of this Agreement is held to be invalid or unenforceable in any respect, the
validity and enforceability of the remaining terms and provisions of this Agreement shall not in any way be
affected or impaired thereby and the parties will attempt to agree upon a valid and enforceable provision that is a
reasonable substitute therefor, and upon so agreeing, shall incorporate such substitute provision in this
Agreement.
6.13. Rescission and Withdrawal Right. Notwithstanding anything to the contrary contained in (and without
limiting any similar provisions of) the Transaction Documents, whenever any Investor exercises a right, election,
demand or option under a Transaction Document and the Company does not timely perform its related
obligations within the periods therein provided, then such Investor may rescind or withdraw, in its sole discretion
from time to time upon written notice to the Company, any relevant notice, demand or election in whole or in
part without prejudice to its future actions and rights.
6.14. Replacement of Shares. If any certificate or instrument evidencing any Shares is mutilated, lost, stolen or
destroyed, the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation
thereof, or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence
reasonably satisfactory to the Company of such loss, theft or destruction and customary and reasonable
indemnity, if
23
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (24 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
requested. The applicants for a new certificate or instrument under such circumstances shall also pay any
reasonable third-party costs associated with the issuance of such replacement Shares. If a replacement certificate
or instrument evidencing any Shares is requested due to a mutilation thereof, the Company may require delivery
of such mutilated certificate or instrument as a condition precedent to any issuance of a replacement.
6.15. Remedies. In addition to being entitled to exercise all rights provided herein or granted by law, including
recovery of damages, each of the Investors and the Company will be entitled to specific performance under the
Transaction Documents. The parties agree that monetary damages may not be adequate compensation for any
loss incurred by reason of any breach of obligations described in the foregoing sentence and hereby agrees to
waive in any action for specific performance of any such obligation the defense that a remedy at law would be
adequate.
6.16. Payment Set Aside. To the extent that the Company makes a payment or payments to any Investor pursuant
to any Transaction Document or an Investor enforces or exercises its rights thereunder, and such payment or
payments or the proceeds of such enforcement or exercise or any part thereof are subsequently invalidated,
declared to be fraudulent or preferential, set aside, recovered from, disgorged by or are required to be refunded,
repaid or otherwise restored to the Company, a trustee, receiver or any other person under any law (including,
without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to
the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall be revived
and continued in full force and effect as if such payment had not been made or such enforcement or setoff had
not occurred.
6.17. Independent Nature of Investors’ Obligations and Rights. The obligations of each Investor under any
Transaction Document are several and not joint with the obligations of any other Investor, and no Investor shall
be responsible in any way for the performance of the obligations of any other Investor under any Transaction
Document. The decision of each Investor to purchase Shares pursuant to the Transaction Documents has been
made by such Investor independently of any other Investor. Nothing contained herein or in any Transaction
Document, and no action taken by any Investor pursuant thereto, shall be deemed to constitute the Investors as a
partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Investors
are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated
by the Transaction Documents. Each Investor acknowledges that no other Investor has acted as agent for such
Investor in connection with making its investment hereunder and that no Investor will be acting as agent of such
Investor in connection with monitoring its investment in the Shares or enforcing its rights under the Transaction
Documents. Each Investor shall be entitled to independently protect and enforce its rights, including without
limitation the rights arising out of this Agreement or out of the other Transaction Documents, and it shall not be
necessary for any other Investor to be joined as an additional party in any proceeding for such purpose. The
Company acknowledges that each of the Investors has been provided with the same Transaction Documents for
the purpose of closing a transaction with multiple Investors and not because it was required or requested to do so
by any Investor.
24
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (25 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
6.18. Limitation of Liability. Notwithstanding anything herein to the contrary, the Company acknowledges and
agrees that the liability of an Investor arising directly or indirectly, under any Transaction Document of any and
every nature whatsoever shall be satisfied solely out of the assets of such Investor, and that no trustee, officer,
other investment vehicle or any other Affiliate of such Investor or any investor, shareholder or holder of shares of
beneficial interest of such a Investor shall be personally liable for any liabilities of such Investor.
[REMAINDER OF PAGE INTENTIONALLY LEFT
BLANK SIGNATURE PAGES FOLLOW]
25
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (26 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly
executed by their respective authorized signatories as of the date first indicated above.
VERI-TEK INTERNATIONAL, CORP.
/s/ David J. Langevin
Name: David J. Langevin
Title: CEO
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK
SIGNATURE PAGES FOR INVESTORS FOLLOW]
26
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (27 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly
executed by their respective authorized signatories as of the date first indicated above.
NAME OF INVESTOR
SKYLANDS QUEST LLC
By: /s/ Charles A. Paquelet
Name: Charles A. Paquelet
Title: President—Skylands Capital, LLC
Managing Member of Skylands Quest
LLC
Investment Amount: $106,800
Tax ID No.: 39-1838444
ADDRESS FOR NOTICE
c/o:
Skylands Capital, LLC
Street:
1200 N. Mayfair Rd. Ste 250
City/State/ Milwaukee, WI 53213
Zip:
Attention:
Steve Pulito
Tel:
414-256-3385
Fax:
414-256-3396
DELIVERY INSTRUCTIONS
(if different from above)
c/o:
same as above
Street:
City/State/
Zip:
Attention:
Tel:
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (28 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
27
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (29 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly
executed by their respective authorized signatories as of the date first indicated above.
NAME OF INVESTOR
SKYLANDS SPECIAL INVESTMENT
LLC
By: /s/ Charles A. Paquelet
Name: Charles A. Paquelet
Title: President—Skylands Capital, LLC,
Managing Member of Skylands Special
Investment LLC
Investment Amount: $313,800
Tax ID No.: 39-1738922
ADDRESS FOR NOTICE
c/o:
Skylands Capital, LLC
Street:
1200 N. Mayfair Rd. Ste 250
City/State/ Milwaukee, WI 53213
Zip:
Attention:
Steve Pulito
Tel:
414-256-3385
Fax:
414-256-3396
DELIVERY INSTRUCTIONS
(if different from above)
c/o:
same as above
Street:
City/State/
Zip:
Attention:
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (30 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
Tel:
28
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (31 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly
executed by their respective authorized signatories as of the date first indicated above.
NAME OF INVESTOR
SKYLANDS SPECIAL INVESTMENT II
LLC
By: /s/ Charles A. Paquelet
Name: Charles A. Paquelet
Title: President—Skylands Capital, LLC
Managing Member of Skylands Special
Investment II LLC
Investment Amount: $58,800
Tax ID No.: 14-1927885
ADDRESS FOR NOTICE
c/o:
Skylands Capital, LLC
Street:
1200 N. Mayfair Rd. Ste 250
City/State/ Milwaukee, WI 53213
Zip:
Attention:
Steve Pulito
Tel:
414-256-3385
Fax:
414-256-3396
DELIVERY INSTRUCTIONS
(if different from above)
c/o:
same as above
Street:
City/State/
Zip:
Attention:
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (32 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
Tel:
29
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (33 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly
executed by their respective authorized signatories as of the date first indicated above.
NAME OF INVESTOR
HARBOUR HOLDINGS LTD.
By: /s/ Charles A. Paquelet
Name: Charles A. Paquelet
Title: Director
Investment Amount: $720,600
Tax ID No.: N.A. Bermuda Company
ADDRESS FOR NOTICE
c/o:
Skylands Capital, LLC
Street:
1200 N. Mayfair Rd. Ste 250
City/State/ Milwaukee, WI 53213
Zip:
Attention:
Steve Pulito
Tel:
414-256-3385
Fax:
414-256-3396
DELIVERY INSTRUCTIONS
(if different from above)
c/o:
same as above
Street:
City/State/
Zip:
Attention:
Tel:
30
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (34 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly
executed by their respective authorized signatories as of the date first indicated above.
NAME OF INVESTOR
LAKE STREET FUND, L.P.
By: /s/ Scott W. Hood
Name: Scott W. Hood
Title: Managing Director
Investment Amount: $600,000
Tax ID No.: 02-0638508
ADDRESS FOR NOTICE
c/o:
First Wilshire Securities
Management, Inc.
Street:
1224 East Green Street, Suite
200
City/State/ Pasadena, California 91106
Zip:
Attention:
Scott W. Hood
Tel:
626-796-6622
Fax:
626-796-8990
DELIVERY INSTRUCTIONS
(if different from above)
c/o:
same as above
Street:
City/State/
Zip:
Attention:
Tel:
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (35 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
31
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (36 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly
executed by their respective authorized signatories as of the date first indicated above.
NAME OF INVESTOR
ALDER CAPITAL PARTNERS I, L.P.
By: /s/ Michael Licosati
Name: Michael Licosati
Title: Managing Partner, Alder Capital,
LLC
Investment Amount: $1,076,400
Tax ID No.: 22-3843864
ADDRESS FOR NOTICE
c/o:
Michael Licosati
Street:
12750 High Bluff Drive, Suite
120
City/State/ San Diego, CA 92130
Zip:
Attention:
Michael Licosati
Tel:
858-259-3900 x 101
Fax:
858-259-3272
DELIVERY INSTRUCTIONS
(if different from above)
c/o:
UBS
Street:
555 California Street, Ste 4650
City/State/ San Francisco, CA 94104
Zip:
Attention:
Marcus Javier
Tel:
415-352-5643
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (37 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
32
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (38 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly
executed by their respective authorized signatories as of the date first indicated above.
NAME OF INVESTOR
ALDER OFFSHORE PARTNERS, LTD
By: /s/ Michael Licosati
Name: Michael Licosati
Title: Managing Partner, Alder Capital,
LLC
Investment Amount: $423,600
Tax ID No.: 98-0454468
ADDRESS FOR NOTICE
c/o:
Michael Licosati
Street:
12750 High Bluff Drive, Suite
120
City/State/ San Diego, CA 92130
Zip:
Attention:
Michael Licosati
Tel:
858-259-3900 x 101
Fax:
858-259-3272
DELIVERY INSTRUCTIONS
(if different from above)
c/o:
UBS
Street:
555 California Street, Ste 4650
City/State/ San Francisco, CA 94104
Zip:
Attention:
Marcus Javier
Tel:
415-352-5643
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (39 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
33
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (40 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly
executed by their respective authorized signatories as of the date first indicated above.
NAME OF INVESTOR
SUNRISE EQUITY PARTNERS, L.P.
By: /s/ Marilyn S. Adler
Name: Marilyn S. Adler
Title: Manager, Level Counter, LLC, the
general partner of Sunrise Equity
Partners, LP
Investment Amount: $360,000
Tax ID No.: 55-0843670
ADDRESS FOR NOTICE
c/o:
Sunrise Equity Partners, L.P.
Street:
641 Lexington Avenue 25th
Floor
City/State/ New York, NY 10022
Zip:
Attention:
Marilyn S. Adler
Tel:
212-421-1616 x 145
Fax:
212-750-7277
DELIVERY INSTRUCTIONS
(if different from above)
c/o:
same as above
Street:
City/State/
Zip:
Attention:
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (41 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
Tel:
34
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (42 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly
executed by their respective authorized signatories as of the date first indicated above.
NAME OF INVESTOR
PIERCE DIVERSIFIED STRATEGY
MASTER
FUND LLC, ENA
By: /s/ Adam Epstein
Name: Adam Epstein
Title: Principal
Investment Amount: $100,500
Tax ID No.: 20-3911089
ADDRESS FOR NOTICE
c/o:
Pierce Diversified Strategy
Master Fund, LLC, Ena
Street:
One Ferry Building Suite 255
City/State/ San Francisco, CA 94111
Zip:
Attention:
Adam Epstein
Tel:
415-677-1579
Fax:
415-677-1580
DELIVERY INSTRUCTIONS
(if different from above)
c/o:
same as above
Street:
City/State/
Zip:
Attention:
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (43 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
Tel:
35
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (44 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly
executed by their respective authorized signatories as of the date first indicated above.
NAME OF INVESTOR
ENABLE OPPORTUNITY PARTNERS
LP
By: /s/ Adam Epstein
Name: Adam Epstein
Title: Principal
Investment Amount: $201,000
Tax ID No.: 20-1204059
ADDRESS FOR NOTICE
c/o:
Enable Opportunity Partners LP
Street:
One Ferry Building Suite 255
City/State/ San Francisco, CA 94111
Zip:
Attention:
Adam Epstein
Tel:
415-677-1579
Fax:
415-677-1580
DELIVERY INSTRUCTIONS
(if different from above)
c/o:
same as above
Street:
City/State/
Zip:
Attention:
Tel:
36
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (45 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (46 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly
executed by their respective authorized signatories as of the date first indicated above.
NAME OF INVESTOR
ENABLE GROWTH PARTNERS LP
By: /s/ Adam Epstein
Name: Adam Epstein
Title: Principal
Investment Amount: $1,708,500
Tax ID No.: 75-3030215
ADDRESS FOR NOTICE
c/o:
Enable Growth Partners LP
Street:
One Ferry Building Suite 255
City/State/ San Francisco, CA 94111
Zip:
Attention:
Adam Epstein
Tel:
415-677-1579
Fax:
415-677-1580
DELIVERY INSTRUCTIONS
(if different from above)
c/o:
same as above
Street:
City/State/
Zip:
Attention:
Tel:
37
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (47 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly
executed by their respective authorized signatories as of the date first indicated above.
NAME OF INVESTOR
THE PINNACLE FUND, LP
By: /s/ Barry M. Kitt
Name: Barry M. Kitt
Title: Sole Member, Pinnacle Fund
Management, L.L.C., the General
Partner of Pinnacle Advisers, L.P., the
General Partner of The Pinnacle Fund, L.
P.
Investment Amount: $3,330,000
Tax ID No.: 75-2512784
ADDRESS FOR NOTICE
c/o:
The Pinnacle Fund, LP
Street:
4965 Preston Park Blvd., Ste
240
City/State/ Plano, TX 75093
Zip:
Attention:
Barry M. Kitt
Tel:
972-985-2121
Fax:
972-985-2122
DELIVERY INSTRUCTIONS
(if different from above)
c/o:
Banc of America Securities
Street:
901 Main Street, Suite 6616
City/State/ Dallas, TX 75202
Zip:
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (48 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
Attention:
Brett Speer
Tel:
214-209-9973
38
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (49 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
Annex A
SCHEDULE OF BUYERS
(1)
(2)
Address and
Facsimile Number
Buyer
Skylands Quest
1200 N. Mayfair Rd. Ste 250
LLC
Milwaukee, WI 53213
414-256-3396
Skylands Special c/o: Skylands Capital, LLC
Investment LLC 1200 N. Mayfair Rd. Ste 250
Milwaukee, WI 53213
414-256-3396
Skylands Special c/o: Skylands Capital, LLC
Investment II
1200 N. Mayfair Rd. Ste 250
LLC
Milwaukee, WI 53213
414-256-3396
Harbour Holdings c/o: Skylands Capital, LLC
Ltd
1200 N. Mayfair Rd. Ste 250
Milwaukee, WI 53213
414-256-3396
Lake Street Fund, c/o: First Wilshire Securities
LP
Management, Inc.
1224 East Green Street, Suite 200
Pasadena, California 91106
626-796-8990
Alder Capital
c/o: Michael Licosati
Partners I, LP
12750 High Bluff Drive, Suite 120
San Diego, CA 92130
858-259-3272
Alder Offshore
c/o: Michael Licosati
Partners, Ltd
12750 High Bluff Drive, Suite 120
San Diego, CA 92130
858-259-3272
Sunrise Equity
641 Lexington Avenue 25th Floor
Partners, LP
New York, NY 10022
212-750-7277
Pierce Diversified One Ferry Building Suite 255
Strategy Master
San Francisco, CA 94111
Fund, LLC, Ena 415-677-1580
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (50 of 51) [8/31/2007 3:28:00 PM]
Securities Purchase Agreement
Enable
Opportunity
Partners LP
The Pinnacle
Fund, LP
One Ferry Building Suite 255
San Francisco, CA 94111
415-677-1580
4965 Preston Park Blvd., Ste 240
Plano, TX 75093
972-985-2122
39
http://www.sec.gov/Archives/edgar/data/1302028/000119312507193814/dex101.htm (51 of 51) [8/31/2007 3:28:00 PM]
`